Bioretec Oy

BRETEC

FI4000480454

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki 12:00:00 2026-10-23 EDT			5-day change	1st Jan Change
0.0214 ^EUR	0.00%		-4.46%	-96.43%

10-08	Bioretec to Start Change Negotiations; Up to 13 Employees Affected	MT
09-06	US FDA Allows Bioretec to Commercialize Bioabsorbable Compression Screw	MT

Bioretec's CFO Steps Down

Published on 07/02/2026 at 12:04 pm EDT

MT Newswires

This article is reserved for our members.

Continue with Google Continue with Apple Continue with LinkedIn

or by email

Continue with an email.

Latest news about Bioretec Oy

10-08	Bioretec to Start Change Negotiations; Up to 13 Employees Affected	MT
09-06	US FDA Allows Bioretec to Commercialize Bioabsorbable Compression Screw	MT
09-05	Bioretec Receives FDA 510(k) Clearance For ActivaScrew Cannulated COM Bioabsorbable Compression Screw	CI
08-05	Medical Device Company Bioretec Appoints New CFO	MT
08-05	Bioretec Ltd Announces Appointment of Panu Mikkonen as Chief Financial Officer, Effective October 6, 2026	CI
07-02	Bioretec's CFO Steps Down	MT
07-02	Bioretec Ltd Announces CFO Changes, Effective July 2, 2026	CI
06-17	Bioretec Oy Appoints Conan Cavanagh as Head of Research & Development and Member of the Management Team as of 1 September 2026	CI
06-17	Bioretec to Terminate Three Production Roles in Finland	MT
06-06	Bioretec Ltd Announces U.S. Department of Health and Human Services Food and Drug Administration Issues a Final Order	CI
06-02	Bioretec Launches Change Negotiations Across Finnish Production Business	MT
05-13	Bioretec clarifies its 2026-2028 financial target regarding the sales margin	RE
05-13	Bioretec clarifies 2026-2028 financial target regarding sales margin	RE
05-08	Bioretec Ltd Announces Board Changes	CI
04-27	Bioretec Raises EUR13 Million from Rights Offering	MT

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oyâ€™s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Companyâ€™s products are used all over the world.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

11-11 Earnings release - Q3 2026

More about the company